Table 1

Tetracycline-repressible lethality in LA513A.

Cross
Parents

Progeny











Male
Female
Tc
Genotype
Egg
L1
L2
L3
L4
Pupae
Adults
%

a
LA513A/+
+/+
Yes
LA513A/+
1000
489
468
446
442
437
434
89




Wild type

444
431
403
400
396
392
88
b
+/+
LA513A/+
Yes
LA513A/+
1000
442
420
404
399
393
383
87




Wild type

466
444
428
417
412
404
87
c
LA513A/+
+/+
No
LA513A/+
540
274
265
235
208
155
7
2.6




Wild type

233
225
214
212
209
206
88
d
+/+
LA513A/+
No
LA513A/+
497
216
205
181
168
131
9
4.2




Wild type

241
225
216
214
211
207
86

Adults heterozygous for LA513A were allowed to mate with wild type. a and c: transgenic males crossed to wild type females; b, d: the reciprocal cross using transgenic females. Eggs were collected and the resulting larvae reared in media supplemented with tetracycline (Tc) to 30 μg/ml (crosses a and b) or in normal, tetracycline-free media (crosses c and d). Data are the sum of at least 5 experiments. The ratio of transgenic to non-transgenic first instar larvae (L1) was approximately 1:1 (1421:1384), indicating that there was no significant differential embryonic mortality between transgenic and wild type (binomial exact test,p = 0.248). The numbers of transgenic and non-transgenic first, second, third and fourth instar larvae (L1–L4), pupae and adults resulting from these eggs is shown. In the absence of tetracycline, the transgenics showed very high (96–97%) mortality between first instar larvae and adult stages (highlighted cells); this was completely suppressed by tetracycline. Mortality of transgenics in the absence of tetracycline is strongly stage-specific, being primarily around the pupal stage (L4-pupae and pupae-adult; most affected individuals started to pupate but failed to develop beyond the earliest stages of pupal development).

Phuc et al. BMC Biology 2007 5:11   doi:10.1186/1741-7007-5-11